AbbVie Inc. buy melinda
Start price
12.03.18
/
50%
€107.50
Target price
28.03.18
€113.52
Performance (%)
-20.52%
End price
28.03.18
€85.45
Summary
This prediction ended on 28.03.18 with a price of €85.45. The prediction for AbbVie Inc. disappointed with a performance of -20.52%. melinda has a follow-up prediction for AbbVie Inc. where he still thinks AbbVie Inc. is a Buy. melinda has 50% into this predictionAbbVie (ABBV) is a multinational biopharmaceutical company based in North Chicago, Illinois. It was spun off as a separate entity from Abbott Laboratories in 2013 and is primarily focused on the development and commercialization of drugs for the treatment of conditions such as immunology, oncology, and neuroscience. Its key product is Humira, which is used to treat a range of autoimmune diseases, generating a significant portion of the company's revenue. The company also has a pipeline of promising products in various stages of development, making it a reputable player in the pharmaceutical industry.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| AbbVie Inc. | -4.773% | -4.773% | 12.980% | 57.315% |
| iShares Core DAX® | 0.192% | 3.121% | 16.828% | 19.649% |
| iShares Nasdaq 100 | 1.245% | 5.051% | 31.022% | 56.928% |
| iShares Nikkei 225® | -0.992% | 1.101% | 9.804% | 6.691% |
| iShares S&P 500 | 0.154% | 2.864% | 26.511% | 47.657% |
According to melinda what are the pros and cons of AbbVie Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread AbbVie Inc. diskutieren
Pharmazeutische SecteurProduits 14/03 Agenda | 13.00 Uhr Präsentation
Pierre Trottier, Portfolio Manager, Industrie Allianz Investment Management Inc .., Quebec
- Die Wahl: Abbvie Inc. (NYSE-ABBV)
- 52 Wochen: US $ 63,12 bis US $ 125,86 pro Aktie
- Jahresdividendenrendite und US $ 2,63 pro Aktie (2,20%)
(Vom Mitglied beendet)
Current prediction by melinda for AbbVie Inc.
AbbVie Inc.
Start price
Target price
Perf. (%)
€126.10
17.06.23
17.06.23
-
17.06.24
17.06.24
18.66%
09:35
09:35
Could be worthwhile Investment >10% per year
Stopped prediction by melinda for AbbVie Inc.
AbbVie Inc.
Start price
Target price
Perf. (%)
€137.98
05.06.22
05.06.22
€155.00
05.06.23
05.06.23
-7.09%
06.06.23
06.06.23
Could be worthwhile Investment >10% per year
AbbVie Inc.
Start price
Target price
Perf. (%)
€73.20
01.11.19
01.11.19
€98.00
04.11.21
04.11.21
37.84%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
AbbVie Inc.
Start price
Target price
Perf. (%)
€89.22
15.06.18
15.06.18
€189.42
17.12.18
17.12.18
-11.51%
17.12.18
17.12.18
Could be worthwhile Investment >10% per year
AbbVie Inc.
Start price
Target price
Perf. (%)
€85.54
28.03.18
28.03.18
€97.87
23.05.18
23.05.18
11.86%
23.05.18
23.05.18
Could be worthwhile Investment >10% per year
AbbVie Inc.
Start price
Target price
Perf. (%)
€76.18
10.09.17
10.09.17
€81.18
28.09.17
28.09.17
6.74%
28.09.17
28.09.17
Could be worthwhile Investment >10% per year
AbbVie Inc.
Start price
Target price
Perf. (%)
€84.46
10.09.17
10.09.17
€90.00
28.09.17
28.09.17
6.74%
28.09.17
28.09.17
Could be worthwhile Investment >10% per year
AbbVie Inc.
Start price
Target price
Perf. (%)
€64.95
10.08.17
10.08.17
€66.75
30.08.17
30.08.17
2.81%
30.08.17
30.08.17
Could be worthwhile Investment >10% per year
AbbVie Inc.
Start price
Target price
Perf. (%)
€72.01
10.08.17
10.08.17
€74.00
30.08.17
30.08.17
2.81%
30.08.17
30.08.17
Could be worthwhile Investment >10% per year
AbbVie Inc.
Start price
Target price
Perf. (%)
€56.36
07.05.16
07.05.16
€55.92
12.05.16
12.05.16
0.12%
12.05.16
12.05.16
Could be worthwhile Investment >10% per year